20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

The Science Behind J-147: A Novel Approach to Combating Alzheimer's and Aging

In the ongoing battle against age-related cognitive decline and debilitating diseases like Alzheimer's, researchers are constantly seeking novel therapeutic pathways. Among the promising candidates is J-147, an experimental compound that diverges from traditional approaches by focusing on the aging process itself rather than solely targeting amyloid plaques.

J-147, a derivative of curcumin, has demonstrated remarkable neuroprotective and neurogenic effects in preclinical studies. Unlike curcumin, J-147 exhibits superior efficacy in crossing the blood-brain barrier, a critical factor for treating neurological conditions. Its primary mechanism involves interacting with ATP synthase, a crucial enzyme in cellular energy production. The theory behind this approach is that by regulating the overproduction of ATP, which is often linked to the aging process, J-147 can help mitigate age-related cellular damage.

Furthermore, J-147 has shown the ability to boost levels of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF). These neurotrophic factors are vital for the survival, growth, and function of neurons. By increasing NGF and BDNF, J-147 supports brain plasticity, promotes the growth of new nerve cells (neurogenesis), and enhances cognitive functions such as learning and memory. These findings suggest J-147 could be a significant development in treating neurodegenerative disorders and promoting healthy brain aging.

The development of J-147 represents a significant shift in the pharmaceutical approach to aging and neurodegeneration. By focusing on fundamental biological processes rather than disease-specific pathologies, this compound offers a multi-faceted strategy. The ongoing research into J-147 and its derivatives, such as CAD-31 which shows enhanced neurogenic activity, holds immense promise for future therapeutic interventions. For those interested in advanced research compounds, understanding the specific chemical properties and availability of high-purity J-147 powder is crucial for scientific exploration.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: The Versatility of Clindamycin Hydrochloride: From Topical Treatments to Oral Suspensions

Next: Understanding J-147: Mechanisms, Benefits, and Applications in Cognitive Health

All Rights Reserved